JP2008525468A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525468A5 JP2008525468A5 JP2007548436A JP2007548436A JP2008525468A5 JP 2008525468 A5 JP2008525468 A5 JP 2008525468A5 JP 2007548436 A JP2007548436 A JP 2007548436A JP 2007548436 A JP2007548436 A JP 2007548436A JP 2008525468 A5 JP2008525468 A5 JP 2008525468A5
- Authority
- JP
- Japan
- Prior art keywords
- perfusion
- organ
- tissue
- heart
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000000056 organ Anatomy 0.000 claims description 18
- 210000004351 coronary vessel Anatomy 0.000 claims description 14
- 230000000302 ischemic effect Effects 0.000 claims description 9
- 230000010410 reperfusion Effects 0.000 claims description 3
- 230000010412 perfusion Effects 0.000 claims 18
- 210000001519 tissue Anatomy 0.000 claims 12
- 210000002216 heart Anatomy 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 9
- 208000027418 Wounds and injury Diseases 0.000 claims 7
- 230000006378 damage Effects 0.000 claims 7
- 208000014674 injury Diseases 0.000 claims 7
- 239000003112 inhibitor Substances 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 4
- 210000004204 blood vessel Anatomy 0.000 claims 4
- 230000006835 compression Effects 0.000 claims 4
- 238000007906 compression Methods 0.000 claims 4
- 239000003223 protective agent Substances 0.000 claims 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 3
- 230000000747 cardiac effect Effects 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 230000002669 organ and tissue protective effect Effects 0.000 claims 3
- 239000011734 sodium Substances 0.000 claims 3
- 229910052708 sodium Inorganic materials 0.000 claims 3
- 210000004556 brain Anatomy 0.000 claims 2
- IWXNYAIICFKCTM-UHFFFAOYSA-N cariporide Chemical compound CC(C)C1=CC=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O IWXNYAIICFKCTM-UHFFFAOYSA-N 0.000 claims 2
- 229950008393 cariporide Drugs 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 210000001508 eye Anatomy 0.000 claims 2
- 210000000936 intestine Anatomy 0.000 claims 2
- 210000003734 kidney Anatomy 0.000 claims 2
- 210000004185 liver Anatomy 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 210000000496 pancreas Anatomy 0.000 claims 2
- 210000002027 skeletal muscle Anatomy 0.000 claims 2
- 229940088872 Apoptosis inhibitor Drugs 0.000 claims 1
- 101100116570 Caenorhabditis elegans cup-2 gene Proteins 0.000 claims 1
- 229940127291 Calcium channel antagonist Drugs 0.000 claims 1
- 108091006146 Channels Proteins 0.000 claims 1
- 101100116572 Drosophila melanogaster Der-1 gene Proteins 0.000 claims 1
- 229940123271 Endothelin 1 antagonist Drugs 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 1
- 102100030980 Sodium/hydrogen exchanger 1 Human genes 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 239000000158 apoptosis inhibitor Substances 0.000 claims 1
- 239000000480 calcium channel blocker Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 108010093115 growth factor-activatable Na-H exchanger NHE-1 Proteins 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 230000002438 mitochondrial effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- 230000035699 permeability Effects 0.000 claims 1
- FCTRVTQZOUKUIV-MCDZGGTQSA-M potassium;[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound [K+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)([O-])=O)[C@@H](O)[C@H]1O FCTRVTQZOUKUIV-MCDZGGTQSA-M 0.000 claims 1
- 229940125794 sodium channel blocker Drugs 0.000 claims 1
- 239000003195 sodium channel blocking agent Substances 0.000 claims 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 4
- 229960004373 acetylcholine Drugs 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010063837 Reperfusion injury Diseases 0.000 description 2
- 230000008753 endothelial function Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 2
- 230000010413 ischemic postconditioning Effects 0.000 description 2
- 230000010411 postconditioning Effects 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63846104P | 2004-12-22 | 2004-12-22 | |
| PCT/US2005/046417 WO2006069170A2 (en) | 2004-12-22 | 2005-12-20 | Therapeutic adjuncts to enhance the organ protective effects of postconditioning |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008525468A JP2008525468A (ja) | 2008-07-17 |
| JP2008525468A5 true JP2008525468A5 (enExample) | 2009-01-29 |
Family
ID=36602296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007548436A Withdrawn JP2008525468A (ja) | 2004-12-22 | 2005-12-20 | ポストコンディショニング臓器保護作用を増強する治療補助薬 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080097385A1 (enExample) |
| EP (1) | EP1827298A4 (enExample) |
| JP (1) | JP2008525468A (enExample) |
| AU (1) | AU2005319144A1 (enExample) |
| CA (1) | CA2592142A1 (enExample) |
| WO (1) | WO2006069170A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020001797A (ko) | 1999-03-23 | 2002-01-09 | 제임스 쿡 유니버시티 | 신체 기관의 정지, 보호 및 보존 |
| ATE411058T1 (de) | 2001-10-25 | 2008-10-15 | Univ Emory | Katheter für modifizierte perfusion |
| EP3064242A1 (en) | 2003-04-28 | 2016-09-07 | Advanced Circulatory Systems Inc. | Ventilator and methods for treating head trauma and low blood circulation |
| KR101425579B1 (ko) | 2006-05-29 | 2014-08-13 | 하이버네이션 테라퓨틱스 리미티드 | 개선된 조직 유지법 |
| ES2539762T3 (es) | 2006-07-25 | 2015-07-03 | Hibernation Therapeutics, A Kf Llc | Tratamiento de traumatismos |
| US7717855B2 (en) | 2006-12-06 | 2010-05-18 | The Hospital For Sick Children | System for performing remote ischemic preconditioning |
| CA2717162A1 (en) | 2007-03-02 | 2008-09-12 | Hibernation Therapeutics Limited | Transplants |
| US20110046039A1 (en) * | 2007-03-09 | 2011-02-24 | George Mason Intellectual Properties Inc. | Post-exposure prophylaxis and treatment of infections |
| US9352111B2 (en) | 2007-04-19 | 2016-05-31 | Advanced Circulatory Systems, Inc. | Systems and methods to increase survival with favorable neurological function after cardiac arrest |
| US8151790B2 (en) | 2007-04-19 | 2012-04-10 | Advanced Circulatory Systems, Inc. | Volume exchanger valve system and method to increase circulation during CPR |
| CA2731398A1 (en) * | 2007-07-25 | 2009-01-29 | Hibernation Therapeutics Limited | Improved organ protection, preservation and recovery |
| EP2335717A1 (en) * | 2009-11-16 | 2011-06-22 | Institut National De La Recherche Agronomique | PAR-1 antagonists for use in the treatment or prevention of influenza virus type a infections |
| US20110190727A1 (en) * | 2010-02-02 | 2011-08-04 | Boston Scientific Scimed, Inc. | Intervascular catheter, system and method |
| US9724266B2 (en) | 2010-02-12 | 2017-08-08 | Zoll Medical Corporation | Enhanced guided active compression decompression cardiopulmonary resuscitation systems and methods |
| US12016820B2 (en) | 2010-02-12 | 2024-06-25 | Zoll Medical Corporation | Enhanced guided active compression decompression cardiopulmonary resuscitation systems and methods |
| US20120330199A1 (en) * | 2010-07-02 | 2012-12-27 | ResQSystems, Inc. | Methods and systems for reperfusion injury protection after cardiac arrest |
| CN102939054A (zh) * | 2010-03-31 | 2013-02-20 | 儿童医院 | 远端缺血处理改进心肌梗死之后的结果的用途 |
| KR20130040878A (ko) | 2010-04-08 | 2013-04-24 | 더 호스피탈 포 식 칠드런 | 외상성 손상을 위한 원격 허혈 처치의 사용 |
| EP2563446A1 (en) | 2010-04-30 | 2013-03-06 | Abbott Cardiovascular Systems Inc. | Improved balloon catheter exhibiting rapid inflation and deflation |
| US8480650B2 (en) | 2010-04-30 | 2013-07-09 | Abbott Cardiovascular Systems Inc. | Method for increased uptake of beneficial agent and ejection fraction by postconditioning procedures |
| US8821438B2 (en) | 2010-04-30 | 2014-09-02 | Abbott Cardiovascular Systems, Inc. | Catheter system having a fluid circuit |
| US8708996B2 (en) | 2010-04-30 | 2014-04-29 | Abbott Cardiovascular Systems, Inc. | Methods and device for synergistic mitigation of reperfusion injury after an ischemic event |
| US8540669B2 (en) | 2010-04-30 | 2013-09-24 | Abbott Cardiovascular Systems Inc. | Catheter system providing step reduction for postconditioning |
| US9168361B2 (en) | 2010-04-30 | 2015-10-27 | Abbott Cardiovascular Systems Inc. | Balloon catheter exhibiting rapid inflation and deflation |
| JP5770512B2 (ja) * | 2011-03-31 | 2015-08-26 | テルモ株式会社 | 肢部圧迫装置 |
| US9533124B2 (en) | 2011-04-14 | 2017-01-03 | Abbott Cardiovascular Systems Inc. | Reperfusion injury devices |
| JP2014533697A (ja) * | 2011-11-18 | 2014-12-15 | アポテックス テクノロジーズ インコーポレイテッドＡｐｏｔｅｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | デフェリプロンを用いた処置方法 |
| WO2013096495A1 (en) | 2011-12-19 | 2013-06-27 | ResQSystems, Inc. | Systems and methods for therapeutic intrathoracic pressure regulation |
| WO2014199239A2 (en) | 2013-03-15 | 2014-12-18 | The Hospital For Sick Children | Methods relating to the use of remote ischemic conditioning |
| US10098779B2 (en) | 2013-03-15 | 2018-10-16 | The Hospital For Sick Children | Treatment of erectile dysfunction using remote ischemic conditioning |
| WO2014167423A2 (en) | 2013-03-15 | 2014-10-16 | The Hospital For Sick Children | Methods for modulating autophagy using remote ischemic conditioning |
| US9811634B2 (en) | 2013-04-25 | 2017-11-07 | Zoll Medical Corporation | Systems and methods to predict the chances of neurologically intact survival while performing CPR |
| US20140358047A1 (en) | 2013-05-30 | 2014-12-04 | ResQSystems, Inc. | End-tidal carbon dioxide and amplitude spectral area as non-invasive markers of coronary perfusion pressure and arterial pressure |
| BR112016000804A2 (pt) | 2013-07-17 | 2017-08-22 | Hibernation Therapeuitics A Kf Llc | Método para tratar hemorragia, choque e lesão cerebral |
| US10265495B2 (en) | 2013-11-22 | 2019-04-23 | Zoll Medical Corporation | Pressure actuated valve systems and methods |
| US10092591B2 (en) * | 2014-02-27 | 2018-10-09 | University Of Alaska Fairbanks | Methods and compositions for the treatment of ischemic injury to tissue using therapeutic hypothermia |
| KR102667251B1 (ko) * | 2018-01-10 | 2024-05-21 | 터프츠 메디컬 센터, 인크 | 심근 경색 치료시 좌심실 언로딩 시스템 및 방법 |
Family Cites Families (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4781677A (en) * | 1985-07-17 | 1988-11-01 | Wilcox Gilbert M | Method of treatment utilizing a double balloon nasobiliary occlusion catheter |
| US4691708A (en) * | 1986-03-10 | 1987-09-08 | Cordis Corporation | Optical pressure sensor for measuring blood pressure |
| US4769010A (en) * | 1987-02-11 | 1988-09-06 | Strato Medical Corporation | Catheter needle assembly with adjustable height support |
| US4901731A (en) * | 1988-04-27 | 1990-02-20 | Millar Instruments, Inc. | Single sensor pressure differential device |
| US4929236A (en) * | 1988-05-26 | 1990-05-29 | Shiley Infusaid, Inc. | Snap-lock fitting catheter for an implantable device |
| US5011469A (en) * | 1988-08-29 | 1991-04-30 | Shiley, Inc. | Peripheral cardiopulmonary bypass and coronary reperfusion system |
| US4943277A (en) * | 1989-03-24 | 1990-07-24 | Bolling Steven F | Retrograde coronary sinus cardioplegia cannula and method for using same in heart surgery |
| US5129891A (en) * | 1989-05-19 | 1992-07-14 | Strato Medical Corporation | Catheter attachment device |
| DE4003425A1 (de) * | 1990-02-06 | 1991-08-08 | Beyersdorf Friedhelm Dr Med | Reperfusionsvorrichtung |
| US5108369A (en) * | 1990-03-15 | 1992-04-28 | Diagnostic Devices Group, Limited | Dual-diameter multifunction catheter |
| US5190520A (en) * | 1990-10-10 | 1993-03-02 | Strato Medical Corporation | Reinforced multiple lumen catheter |
| US5178612A (en) * | 1990-10-10 | 1993-01-12 | Strato Medical Corporation | Compressible split cylinder bayonet locking device for attachment of a catheter to a fluid transfer device |
| US5156600A (en) * | 1990-10-10 | 1992-10-20 | Strato Medical Corporation | Bidirectional check valve catheter |
| US6309639B1 (en) * | 1991-02-05 | 2001-10-30 | The Board Of Regents Of The University Of Oklahoma | Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand |
| US5112301A (en) * | 1991-06-19 | 1992-05-12 | Strato Medical Corporation | Bidirectional check valve catheter |
| US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
| US5879499A (en) * | 1996-06-17 | 1999-03-09 | Heartport, Inc. | Method of manufacture of a multi-lumen catheter |
| US5769812A (en) * | 1991-07-16 | 1998-06-23 | Heartport, Inc. | System for cardiac procedures |
| US5195942A (en) * | 1991-08-12 | 1993-03-23 | Institute Of Critical Care Medicine | Cardiac arrest treatment |
| US6224619B1 (en) * | 1991-12-17 | 2001-05-01 | Heartport, Inc. | Blood vessel occlusion trocar having size and shape varying insertion body |
| US5224938A (en) * | 1992-03-18 | 1993-07-06 | Strato Medical Corporation | Valved catheter |
| US6325067B1 (en) * | 1992-12-03 | 2001-12-04 | Wesley D. Sterman | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
| US6283127B1 (en) * | 1992-12-03 | 2001-09-04 | Wesley D. Sterman | Devices and methods for intracardiac procedures |
| US5573502A (en) * | 1993-05-26 | 1996-11-12 | Quest Medical, Inc. | Display panel and controls for blood mixture delivery system |
| CN1102851C (zh) * | 1993-06-04 | 2003-03-12 | 生物时间公司 | 类血浆溶液 |
| US5759170A (en) * | 1993-11-30 | 1998-06-02 | Heartport, Inc. | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
| US5478309A (en) * | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
| US5695457A (en) * | 1994-07-28 | 1997-12-09 | Heartport, Inc. | Cardioplegia catheter system |
| US6607698B1 (en) * | 1997-08-15 | 2003-08-19 | Therox, Inc. | Method for generalized extracorporeal support |
| US5868776A (en) * | 1996-09-03 | 1999-02-09 | Ideas For Medicine, Inc. | Overlay dual balloon catheter and method for use thereof |
| US5993382A (en) * | 1996-11-27 | 1999-11-30 | Horizon Medical Products, Inc. | Lighted catheter device and method for use and manufacture thereof |
| DE19702402A1 (de) * | 1997-01-24 | 1998-07-30 | Beyersdorf Friedhelm Univ Prof | Verfahren und Reperfusionsvorrichtung |
| US5957879A (en) * | 1997-01-24 | 1999-09-28 | Heartport, Inc. | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
| US5755687A (en) * | 1997-04-01 | 1998-05-26 | Heartport, Inc. | Methods and devices for occluding a patient's ascending aorta |
| DE19741635A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| US6991645B2 (en) * | 1998-01-23 | 2006-01-31 | Innercool Therapies, Inc. | Patient temperature regulation method and apparatus |
| US6295990B1 (en) * | 1998-02-03 | 2001-10-02 | Salient Interventional Systems, Inc. | Methods and systems for treating ischemia |
| US6736790B2 (en) * | 1998-02-25 | 2004-05-18 | Denise R. Barbut | Method and system for selective or isolated integrate cerebral perfusion and cooling |
| US6235714B1 (en) * | 1998-03-23 | 2001-05-22 | Sudhir Paul | Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| US6602467B1 (en) * | 1998-07-24 | 2003-08-05 | Therox, Inc. | Apparatus and method for blood oxygenation |
| US7914564B2 (en) * | 1999-02-09 | 2011-03-29 | Innercool Therapies, Inc. | System and method for patient temperature control employing temperature projection algorithm |
| US6830581B2 (en) * | 1999-02-09 | 2004-12-14 | Innercool Therspies, Inc. | Method and device for patient temperature control employing optimized rewarming |
| US6315768B1 (en) * | 1999-06-08 | 2001-11-13 | Richard K. Wallace | Perfusion procedure and apparatus for preventing necrosis following failed balloon angioplasty |
| US6576191B1 (en) * | 1999-09-30 | 2003-06-10 | Therox, Inc. | Apparatus for blood oxygenation |
| US6387324B1 (en) * | 1999-09-30 | 2002-05-14 | Therox, Inc. | Apparatus and method for blood oxygenation |
| AU4710401A (en) * | 1999-12-02 | 2001-06-18 | University Of South Florida | Method and composition for treatment of ischemic neuronal reperfusion injury |
| US20030040531A1 (en) * | 2000-01-25 | 2003-02-27 | Kazuyuki Fujishima | Remedies for reperfusion injury containing integrin alphanubeta 3 antagonist |
| US6534651B2 (en) * | 2000-04-06 | 2003-03-18 | Inotek Pharmaceuticals Corp. | 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof |
| US6900178B2 (en) * | 2000-09-12 | 2005-05-31 | University Of Kentucky Research Foundation | Protection against ischemia and reperfusion injury |
| US6645938B2 (en) * | 2000-10-10 | 2003-11-11 | Zymogenetics, Inc. | Protection against ischemia and reperfusion injury |
| US6585675B1 (en) * | 2000-11-02 | 2003-07-01 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
| US6423705B1 (en) * | 2001-01-25 | 2002-07-23 | Pfizer Inc. | Combination therapy |
| US20030216582A1 (en) * | 2001-02-08 | 2003-11-20 | Nicholas Nikolaides | 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| WO2002092124A1 (en) * | 2001-05-11 | 2002-11-21 | Wyeth | Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof |
| US20040131607A1 (en) * | 2001-06-08 | 2004-07-08 | Carroll Michael C. | Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury |
| US6827701B2 (en) * | 2001-07-17 | 2004-12-07 | Kerberos Proximal Solutions | Fluid exchange system for controlled and localized irrigation and aspiration |
| JP2003096308A (ja) * | 2001-09-25 | 2003-04-03 | Asahi Glass Co Ltd | 撥水撥油性組成物およびその造形品 |
| WO2003059266A2 (en) * | 2001-12-21 | 2003-07-24 | Emory University | Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs |
| AU2002352519A1 (en) * | 2001-11-09 | 2003-05-26 | The General Hospital Corporation | Methods for treating ischemic reperfusion injury using ikb kinase-beta inhibitors |
| US6544950B1 (en) * | 2001-12-06 | 2003-04-08 | University Of Kentucky Research Foundation | Seventeen amino acid peptide (Peptide P) for treating ischemia and reperfusion injury |
| US6844361B2 (en) * | 2002-02-04 | 2005-01-18 | Aventis Pharma Deutschland Gmbh | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
| US20030220383A1 (en) * | 2002-02-14 | 2003-11-27 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders |
| AU2003236509A1 (en) * | 2002-06-12 | 2003-12-31 | Biogen Idec Ma Inc. | Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| EP2011489A3 (en) * | 2002-07-09 | 2009-04-22 | Roberta Gottlieb | Method to inhibit ischemia and reperfusion injury |
| US20050143475A1 (en) * | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| BRPI0313155B8 (pt) * | 2002-07-29 | 2021-05-25 | Cardax Pharmaceuticals Inc | composto químico derivado ou análogo de carotenóide, composição farmacêutica, e, uso do composto |
| US20040111079A1 (en) * | 2002-12-03 | 2004-06-10 | Richard Hayes | Targeted sanguinous drug solution delivery to a targeted organ |
| US7004961B2 (en) * | 2003-01-09 | 2006-02-28 | Edward Wong | Medical device and method for temperature control and treatment of the brain and spinal cord |
| WO2004075837A2 (en) * | 2003-02-21 | 2004-09-10 | Tanox, Inc. | Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| PL1608400T3 (pl) * | 2003-03-28 | 2010-11-30 | Faron Pharmaceuticals Oy | Podwyższanie poziomu adenozyny przez indukowaną przez cytokiny ekspresję CD73 |
| US20060051407A1 (en) * | 2003-06-27 | 2006-03-09 | Yoram Richter | Method of treating ischemia-reperfusion injury |
| US20050187221A1 (en) * | 2003-09-08 | 2005-08-25 | Japan Tobacco Inc. | Method of treating ischemia reperfusion injury |
| US20060029589A1 (en) * | 2004-06-01 | 2006-02-09 | Hartmut Weiler | Induction of heterozygous FV Leiden carrier status to reduce mortality in sepsis and to prevent organ damage caused by inflammation and/or ischemia-reperfusion injury |
| US7304073B2 (en) * | 2004-08-20 | 2007-12-04 | Wyeth | Method of treating myocardial ischemia-reperfusion injury using NF-kB inhibitors |
| US20060136023A1 (en) * | 2004-08-26 | 2006-06-22 | Dobak John D Iii | Method and apparatus for patient temperature control employing administration of anti-shivering agents |
| US7332159B2 (en) * | 2004-09-30 | 2008-02-19 | Board Of Regents Of The University Of Nebraska | Method and composition for inhibiting reperfusion injury in the brain |
-
2005
- 2005-12-20 CA CA002592142A patent/CA2592142A1/en not_active Abandoned
- 2005-12-20 EP EP05855042A patent/EP1827298A4/en not_active Withdrawn
- 2005-12-20 WO PCT/US2005/046417 patent/WO2006069170A2/en not_active Ceased
- 2005-12-20 US US11/793,508 patent/US20080097385A1/en not_active Abandoned
- 2005-12-20 JP JP2007548436A patent/JP2008525468A/ja not_active Withdrawn
- 2005-12-20 AU AU2005319144A patent/AU2005319144A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008525468A5 (enExample) | ||
| JP2005514168A5 (enExample) | ||
| EP3352745B1 (en) | Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation | |
| WO2007149283B1 (en) | Use of kw-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload | |
| Caseby et al. | Blast injuries to the lungs: clinical presentation, management and course | |
| JP2009513713A5 (enExample) | ||
| US20040043992A1 (en) | Meloxicam for alleviating organ injury during organ operation or transplantation | |
| CN109417016B (zh) | 用于治疗缺血-再灌注损伤的戊二酸化合物 | |
| JP5519906B2 (ja) | 肝臓疾患の支持療法 | |
| US11253506B2 (en) | Compounds, compositions and methods for preventing and/or treating chlorine inhalation toxicity and/or injury | |
| ES2791301T3 (es) | Combinación de canrenoato y exenatida | |
| US20220273754A1 (en) | Ss-31 for the prevention and/or treatment of aneurysm | |
| CN108815171A (zh) | 25-羟基胆固醇在制备治疗或预防心肌梗死的药物中的应用 | |
| US8980849B2 (en) | Compositions and methods for treating pulmonary hypertension | |
| JP2023523247A (ja) | ウイルス感染症の治療のためのレニン－アンジオテンシン系（ｒａｓ）モジュレーター、それを含む医薬組成物、およびそれを用いた治療方法 | |
| Hatori et al. | Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion | |
| Mckee et al. | A comparison of SMS 201‐995 and oesophageal tamponade in the control of acute variceal haemorrhage | |
| RU2004137109A (ru) | Комбинация блокатора рецептора ангиотензина ii и бетаблокатора для вторичной профилактики инфаркта миокарда | |
| JP2016510738A5 (enExample) | ||
| CN102871990B (zh) | 白藜芦醇的制药用途 | |
| Kizer et al. | Cardiac arrest during laparotomy with argon beam coagulation of metastatic ovarian cancer | |
| Chen et al. | Successful rescue of sustained ventricular tachycardia/ventricular fibrillation after coronary artery bypass grafting by extracorporeal membrane oxygenation. | |
| CN110292637B (zh) | 一种预防、治疗高血压的药物组合物 | |
| WO2005053687A1 (en) | Combination of organic compounds | |
| Nagy | 24-HOUR AMBULATORY BLOOD PRESSURE REDUCTION WITH A PERINDOPRIL/AMLODIPINE FIXED-DOSE COMBINATION: PP. 15.427 |